CA2533173A1 - Method for the production of cyclic phosphonic acid anhydrides - Google Patents
Method for the production of cyclic phosphonic acid anhydrides Download PDFInfo
- Publication number
- CA2533173A1 CA2533173A1 CA002533173A CA2533173A CA2533173A1 CA 2533173 A1 CA2533173 A1 CA 2533173A1 CA 002533173 A CA002533173 A CA 002533173A CA 2533173 A CA2533173 A CA 2533173A CA 2533173 A1 CA2533173 A1 CA 2533173A1
- Authority
- CA
- Canada
- Prior art keywords
- formula
- cyclic
- anhydrides
- iii
- mbar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
- C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/3895—Pyrophosphonic acids; phosphonic acid anhydrides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/10—Process efficiency
Abstract
Disclosed is a method for producing cyclic phosphonic acid anhydrides of formula (III) by a) reacting phosphonic acid derivatives of formula (I) with acetic anhydride at a temperature ranging between 30 and 150 ~C while separating a mixture of ethanoic acid and acetic anhydride by means of distillation, b) then reactively distilling the oligomeric phosphonic acid anhydrides of formula (II) obtained in step a) and transforming the same into the corresponding cyclic trimeric phosphonic acid anhydrides of formula (III), n representing a number between 0 and 300 while R represents allyl, aryl, or open-chain, cyclic, or branched C1 to C8 alkyl radicals, aryloxy, allyloxy, or alkoxy comprising open-chain, cyclic, or branched C1 to C8 alkyl radicals.
Preferably, the cyclic trimeric phosphonic acid anhydrides formed in step b) are immediately dissolved in an organic solvent that exhibits an inert behavior relative thereto.
Preferably, the cyclic trimeric phosphonic acid anhydrides formed in step b) are immediately dissolved in an organic solvent that exhibits an inert behavior relative thereto.
Description
J
Description Method for the production of cyclic phosphoric acid anhydrides The present invention relates to an improved process for preparing known 2,4,6-substituted 1,3,5,2,4,6-trioxatriphosphinane 2,4,6-trioxides (III) from the parent phosphoric acids of the formula (I) via their open-chain analogs of the formula (II) by distillation.
R
distillation . ~ ~ reactive distillation HO-P-OH ~O _ t..~p-.p ~ 1 R-p ~P~O
R R R R ~O ~R
The preparation of the oligomeric phosphoric anhydrides of the formula (II) (OPA) by condensation with a suitable assistant (EP-B-0 527 442) and the use of these OPAs to form amide bonds (DE-A-38 39 379) is already known.
However, to form amide bonds, it is necessary here in accordance with the state of the art to use excesses of OPA because, in the product prepared according to EP 0 527 442, phosphoric anhydrides of chain length PZO - P2~
are prepared and the composition of the OPA is thus not known precisely.
Resulting costs can be avoided by virtue of the cyclic propanephosphonic anhydrides of the formula (III) (CPA) prepared by the process according to the invention.
Phosphoric acids are degraded by microorganisms typically to the phosphate, which is ecologically problematic (eutrophication). The use of the cyclic phosphoric anhydrides (CPA), which is reduced because it is stoichiometric, can prevent this. This achieves a further advantage by the preparation and the use of compounds of the formula (III) compared to the known preparation processes and applications, as described in EP-A-0 527 442 and EP-A-3 839 379.
The selected preparation of CPAs in the laboratory has already succeeded (H. Wissmann, H.J. Kleiner, Angew. Chem. Int. Ed. 1980, 19, 133 [129]).
~
The possibility of a distillation of the CPAs is mentioned here, but it is an additional purifying distillation of CPAs already present as crude products.
Moreover, in this process, the CPAs are prepared using phosphonyl dichlorides.
CI O~
Cl~ i H20 'P'0 , I ~O -1- HCI
1'O'P
O
The HCI formed in this preparation process poses many problems in an industrial application of this synthesis route as a result of its corrosive and toxic properties. An additional fact is that the product comprises chloride, which can restrict the possible uses of the CPAs.
With regard to the aforementioned disadvantages of the known processes, in which a product mixture is obtained in undefined composition, large amounts of waste occur, corrosive and toxic gases form or the product comprises chloride, there is a need to provide an improved process which does not have all of these disadvantages.
This object is achieved by a process for preparing cyclic phosphonic anhydrides of the formula (III) by a) reaction of phosphonic acid alkanes of the formula (I) with acetic anhydride at a temperature in the range from 30 to 150°C and simultaneous distillative removal of a mixture of acetic acid and acetic anhydride, b) subsequent reactive distillation of the oligomeric phosphonic anhydrides of the formula (II) obtained in step a) and conversion to the corresponding cyclic trimeric phosphonic anhydrides of the formula (Ill) O! R
distillation ~ ~ j reactive distillation O' HO-P-OH HO-P-O P-O P-OH
R ~'O R R R
O
~
Description Method for the production of cyclic phosphoric acid anhydrides The present invention relates to an improved process for preparing known 2,4,6-substituted 1,3,5,2,4,6-trioxatriphosphinane 2,4,6-trioxides (III) from the parent phosphoric acids of the formula (I) via their open-chain analogs of the formula (II) by distillation.
R
distillation . ~ ~ reactive distillation HO-P-OH ~O _ t..~p-.p ~ 1 R-p ~P~O
R R R R ~O ~R
The preparation of the oligomeric phosphoric anhydrides of the formula (II) (OPA) by condensation with a suitable assistant (EP-B-0 527 442) and the use of these OPAs to form amide bonds (DE-A-38 39 379) is already known.
However, to form amide bonds, it is necessary here in accordance with the state of the art to use excesses of OPA because, in the product prepared according to EP 0 527 442, phosphoric anhydrides of chain length PZO - P2~
are prepared and the composition of the OPA is thus not known precisely.
Resulting costs can be avoided by virtue of the cyclic propanephosphonic anhydrides of the formula (III) (CPA) prepared by the process according to the invention.
Phosphoric acids are degraded by microorganisms typically to the phosphate, which is ecologically problematic (eutrophication). The use of the cyclic phosphoric anhydrides (CPA), which is reduced because it is stoichiometric, can prevent this. This achieves a further advantage by the preparation and the use of compounds of the formula (III) compared to the known preparation processes and applications, as described in EP-A-0 527 442 and EP-A-3 839 379.
The selected preparation of CPAs in the laboratory has already succeeded (H. Wissmann, H.J. Kleiner, Angew. Chem. Int. Ed. 1980, 19, 133 [129]).
~
The possibility of a distillation of the CPAs is mentioned here, but it is an additional purifying distillation of CPAs already present as crude products.
Moreover, in this process, the CPAs are prepared using phosphonyl dichlorides.
CI O~
Cl~ i H20 'P'0 , I ~O -1- HCI
1'O'P
O
The HCI formed in this preparation process poses many problems in an industrial application of this synthesis route as a result of its corrosive and toxic properties. An additional fact is that the product comprises chloride, which can restrict the possible uses of the CPAs.
With regard to the aforementioned disadvantages of the known processes, in which a product mixture is obtained in undefined composition, large amounts of waste occur, corrosive and toxic gases form or the product comprises chloride, there is a need to provide an improved process which does not have all of these disadvantages.
This object is achieved by a process for preparing cyclic phosphonic anhydrides of the formula (III) by a) reaction of phosphonic acid alkanes of the formula (I) with acetic anhydride at a temperature in the range from 30 to 150°C and simultaneous distillative removal of a mixture of acetic acid and acetic anhydride, b) subsequent reactive distillation of the oligomeric phosphonic anhydrides of the formula (II) obtained in step a) and conversion to the corresponding cyclic trimeric phosphonic anhydrides of the formula (Ill) O! R
distillation ~ ~ j reactive distillation O' HO-P-OH HO-P-O P-O P-OH
R ~'O R R R
O
~
c) the cyclic trimeric phosphonic anhydrides formed preferably being dissolved immediately in an organic solvent which is inert toward them, 5. where n is an integer from 0 to 300 and R are H, fluorine, chlorine, bromium, iodine, allyl, aryl or open-chain or branched C~ to C$-alkyl radicals, aryloxy, allyloxy or alkoxy having open-chain or branched C~ to Ce-alkyl radicals, nitro, nitrite, carboxy, carboxylic esters having open-chain or branched C~ to Ca-alkyl radicals, amide or alkylamide radicals having open-chain or branched C~ to C8-alkyl radicals.
In the process according to the invention, the OPAs of the formula (1l) obtained in step a) are converted directly to CPAs of the formula (!1l) by a reactive distillation and, immediately after they are obtained, dissolved in a suitable solvent. In this way, it is possible to prevent immediate polymerization of the CPAs to reform the oligomeric phosphonic anhydrides.
Suitable solvents are those which do not react with the phosphonic anhydrides, these in particular being aprotic organic solvents.
Suitable solvents are all aprotic organic solvents which do not react with the CPA of the formula (ill), preference being given to ligroin, pentane, hexane, heptane, octane, cyclopentane, cyclohexane, cycloheptane, cyclooctane, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,1,2,2-tetrachloroethane, methyl acetate, ethyl acetate, propyl acetate, butyl acetate, dimethylformamide, diethylformamide, dimethylacetamide, diethylacetamide, diethyl ether, diisopropyl ether, tert-butyl methyl ether, THF, dioxane, acetonitrile, sulfolane, DMSO, HMPT, NMP or mixtures thereof, particular preference to dichloromethane, chloroform, ethyl acetate, propyl acetate, butyl acetate, dimethylformamide, diethylformamide, dimethylacetamide, diethylacetamide, diisopropyl ether, tert-butyl methyl ether, THF, dioxane, acetonitrile or mixtures thereof, very particular preference to dichloromethane, chloroform, ethyl acetate, butyl acetate, dimethylformamide, dimethylacetamide, tert-butyl methyl ether, THF, dioxane, acetonitrile or mixtures thereof.
In the process according to the invention, the OPAs of the formula (1l) obtained in step a) are converted directly to CPAs of the formula (!1l) by a reactive distillation and, immediately after they are obtained, dissolved in a suitable solvent. In this way, it is possible to prevent immediate polymerization of the CPAs to reform the oligomeric phosphonic anhydrides.
Suitable solvents are those which do not react with the phosphonic anhydrides, these in particular being aprotic organic solvents.
Suitable solvents are all aprotic organic solvents which do not react with the CPA of the formula (ill), preference being given to ligroin, pentane, hexane, heptane, octane, cyclopentane, cyclohexane, cycloheptane, cyclooctane, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,1,2,2-tetrachloroethane, methyl acetate, ethyl acetate, propyl acetate, butyl acetate, dimethylformamide, diethylformamide, dimethylacetamide, diethylacetamide, diethyl ether, diisopropyl ether, tert-butyl methyl ether, THF, dioxane, acetonitrile, sulfolane, DMSO, HMPT, NMP or mixtures thereof, particular preference to dichloromethane, chloroform, ethyl acetate, propyl acetate, butyl acetate, dimethylformamide, diethylformamide, dimethylacetamide, diethylacetamide, diisopropyl ether, tert-butyl methyl ether, THF, dioxane, acetonitrile or mixtures thereof, very particular preference to dichloromethane, chloroform, ethyl acetate, butyl acetate, dimethylformamide, dimethylacetamide, tert-butyl methyl ether, THF, dioxane, acetonitrile or mixtures thereof.
During the reactive distillation, after the full distillative removal of acetic acid and unconverted acetic anhydride under reduced pressure, the present OPA of the formula (II) (preparation analogous to EP-B-0 527 442) is dissociated at a vacuum of from 0.001 mbar to 500 mbar and a 5. temperature of from 100°C to 450°C to obtain CPAs of the formula (III) in pure form.
The process according to the invention has the particular feature that, in contrast to the processes known to date, only a low level of apparatus complexity is required, since the preparation of the OPAs of the formula (II) and the reactive distillation to prepare the CPAs of the formula (Ill) can be carried out in the same reaction vessel.
It should be regarded as very surprising that the formation of the cyclic compounds (III) succeeds by a reactive distillation. The selectived conditions in the distillation can afford the desired CPA in pure form; no reoligomerization takes place.
As mentioned above, suitable R radicals in the formulae (I), (II) and (III) are allyl, aryl or open-chain cyclic or branched C, to C$-alkyl radicals, aryloxy, allyloxy or alkoxy having open-chain cyclic or branched C~ to C8-alkyl radicals. Particularly suitable radicals are those where R = methyl, ethyl, n-propyl, isopropyl, n-butyl, 2-butyl, isobutyl, pentyl, hexyl; very particularly suitable are ethyl, propyl and butyl radicals.
The ratio of acetic anhydride to the phosphonic acid of the formula (I) can be selected as desired, but should not be too small and is preferably in the range between 20:1 and 1:1, more preferably between 10:1 and 1:1 and most preferably between 5:1 and 1:1.
The reaction and distillation in the process according to the invention takes place in two stages, and consists a) of the condensation of phosphonic acids of the formula (I) to give OPAs of the formula (II) with simultaneous distillation of acetic acid and unconverted acetic anhydride in a temperature range from 30°C to 150°C
(internal reactor temperature) or from 30°C to 130°C (top temperature), but preferably in the temperature range from 50°C to 130°C (the internal reactor temperature) or from 35°C to 100°C (top temperature), most preferably in the temperature range from 70°C to 110°C (the internal ' CA 02533173 2006-O1-20 reactor temperature) or from 40°C to 70°C (top temperature), and b) of the reactive distillation of the OPA of the formula (II) to give CPA
of the formula (III), which is effected in the temperature range of 100°C and 450°C (the internal reactor temperature) or from 100°C to 380°C (top 5 temperature), but preferably in temperature range of 150°C and 400°C (the internal reactor temperature) or from 150°C to 350°C (top temperature), more preferably in the temperature range of 200°C and 350°C (the internal reactor temperature) or from 200°C to 300°C (top temperature).
In the process according to the invention, the pressure in a) the distillation of acetic acid and unconverted acetic anhydride is in the range from 1 mbar and 1000 mbar, preferably in the range from 10 mbar to 500 mbar, more preferably in the range from 50 mbar to 200 mbar, and in b) the reactive distillation of the OPA of the formula (II) to give CPA of the formula (ill) is within a pressure range from 0.001 mbar to 500 mbar, preferably in the range from 0.005 mbar to 100 mbar, more preferably in the range from 0.01 mbar to 50 mbar.
The distillation may be effected over any period; frequently, a) the distillation of acetic acid and acetic anhydride takes place, however, within 100 h, preferably within 80 h, more preferably within 60 h, and b) the reactive distillation of OPA of the formula (II) to CPA of the formula (III) within 120 h, preferably within 90 h, more preferably within 60 h.
It has generally been observed that the distillation and the reactive distillation can be carried out on small scales within a relatively short period, while the reaction times increase on conversion, for example, to the pilot-plant scale.
The resulting CPA of the formula (III) is dissolved in an organic solvent immediately after the distillation; the mixing ratio between solvent and CPA
may be selected as desired, but should not be selected at too low a level owing to the viscosity of the compound, and is preferably in the range of 10:1 and 1:10, more preferably in the range of 5:1 and 1:5, most preferably in the range of 2:1 and 1:2. In a preferred embodiment, the CPA
The process according to the invention has the particular feature that, in contrast to the processes known to date, only a low level of apparatus complexity is required, since the preparation of the OPAs of the formula (II) and the reactive distillation to prepare the CPAs of the formula (Ill) can be carried out in the same reaction vessel.
It should be regarded as very surprising that the formation of the cyclic compounds (III) succeeds by a reactive distillation. The selectived conditions in the distillation can afford the desired CPA in pure form; no reoligomerization takes place.
As mentioned above, suitable R radicals in the formulae (I), (II) and (III) are allyl, aryl or open-chain cyclic or branched C, to C$-alkyl radicals, aryloxy, allyloxy or alkoxy having open-chain cyclic or branched C~ to C8-alkyl radicals. Particularly suitable radicals are those where R = methyl, ethyl, n-propyl, isopropyl, n-butyl, 2-butyl, isobutyl, pentyl, hexyl; very particularly suitable are ethyl, propyl and butyl radicals.
The ratio of acetic anhydride to the phosphonic acid of the formula (I) can be selected as desired, but should not be too small and is preferably in the range between 20:1 and 1:1, more preferably between 10:1 and 1:1 and most preferably between 5:1 and 1:1.
The reaction and distillation in the process according to the invention takes place in two stages, and consists a) of the condensation of phosphonic acids of the formula (I) to give OPAs of the formula (II) with simultaneous distillation of acetic acid and unconverted acetic anhydride in a temperature range from 30°C to 150°C
(internal reactor temperature) or from 30°C to 130°C (top temperature), but preferably in the temperature range from 50°C to 130°C (the internal reactor temperature) or from 35°C to 100°C (top temperature), most preferably in the temperature range from 70°C to 110°C (the internal ' CA 02533173 2006-O1-20 reactor temperature) or from 40°C to 70°C (top temperature), and b) of the reactive distillation of the OPA of the formula (II) to give CPA
of the formula (III), which is effected in the temperature range of 100°C and 450°C (the internal reactor temperature) or from 100°C to 380°C (top 5 temperature), but preferably in temperature range of 150°C and 400°C (the internal reactor temperature) or from 150°C to 350°C (top temperature), more preferably in the temperature range of 200°C and 350°C (the internal reactor temperature) or from 200°C to 300°C (top temperature).
In the process according to the invention, the pressure in a) the distillation of acetic acid and unconverted acetic anhydride is in the range from 1 mbar and 1000 mbar, preferably in the range from 10 mbar to 500 mbar, more preferably in the range from 50 mbar to 200 mbar, and in b) the reactive distillation of the OPA of the formula (II) to give CPA of the formula (ill) is within a pressure range from 0.001 mbar to 500 mbar, preferably in the range from 0.005 mbar to 100 mbar, more preferably in the range from 0.01 mbar to 50 mbar.
The distillation may be effected over any period; frequently, a) the distillation of acetic acid and acetic anhydride takes place, however, within 100 h, preferably within 80 h, more preferably within 60 h, and b) the reactive distillation of OPA of the formula (II) to CPA of the formula (III) within 120 h, preferably within 90 h, more preferably within 60 h.
It has generally been observed that the distillation and the reactive distillation can be carried out on small scales within a relatively short period, while the reaction times increase on conversion, for example, to the pilot-plant scale.
The resulting CPA of the formula (III) is dissolved in an organic solvent immediately after the distillation; the mixing ratio between solvent and CPA
may be selected as desired, but should not be selected at too low a level owing to the viscosity of the compound, and is preferably in the range of 10:1 and 1:10, more preferably in the range of 5:1 and 1:5, most preferably in the range of 2:1 and 1:2. In a preferred embodiment, the CPA
condensate is collected directly in the inert organic solvent in order to prevent polymerization and reformation to give the analogous oligomers.
The thus prepared solution of CPA of the formula (III) and the selected solvent or solvent mixture can be used directly for condensation reactions such as amide formations (M. Feigel et al., Angew. Chem. /nt. Ed. 1989, 28, 486 [466]) and ester formations (F.-P. Montforts et al., Eur. J. Org.
Chem. 2001, 1681-1687), acylations (DE 100 63 493) and for the preparation of heterocycles (WO 99/37620).
In particular, the process according to the invention has the advantage over the prior art that a compound of the formula (III) of defined molar mass is formed from the different oligomers of the formula (II) and can thus be used in stoichiometric amounts. This increases the economic viability of the use of these phosphonic anhydrides in chemical processes, for example in condensation reactions of carboxylic acids with alcohols or amines. The dissolution of the syrupy compound in an organic solvent allows it to be handled particularly easily and it can surprisingly also be used directly in a multitude of reactions in this form.
The thus obtained solutions can in particular form amide bonds and the coupling reagent can be added in a defined and sparing amount.
The examples and comparative examples which follow serve to illustrate the subject matter of the invention without any intention that the invention be restricted to these examples.
The thus prepared solution of CPA of the formula (III) and the selected solvent or solvent mixture can be used directly for condensation reactions such as amide formations (M. Feigel et al., Angew. Chem. /nt. Ed. 1989, 28, 486 [466]) and ester formations (F.-P. Montforts et al., Eur. J. Org.
Chem. 2001, 1681-1687), acylations (DE 100 63 493) and for the preparation of heterocycles (WO 99/37620).
In particular, the process according to the invention has the advantage over the prior art that a compound of the formula (III) of defined molar mass is formed from the different oligomers of the formula (II) and can thus be used in stoichiometric amounts. This increases the economic viability of the use of these phosphonic anhydrides in chemical processes, for example in condensation reactions of carboxylic acids with alcohols or amines. The dissolution of the syrupy compound in an organic solvent allows it to be handled particularly easily and it can surprisingly also be used directly in a multitude of reactions in this form.
The thus obtained solutions can in particular form amide bonds and the coupling reagent can be added in a defined and sparing amount.
The examples and comparative examples which follow serve to illustrate the subject matter of the invention without any intention that the invention be restricted to these examples.
Examples:
Example 1: synthesis of 2,4,6-tripropyl-[1,3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide In a glass flask with stirrer, stopper, internal thermometer and distillation column, 33.0 g of propanephosphonic acid (0.27 mol) are dissolved under argon in 189.3 g of acetic anhydride (1.85 mol) and heated to reflux for 2 h.
Subsequently, the mixture of acetic acid and acetic anhydride is distilled off at 100 mbar. The external temperature is increased to 350°C and the vacuum to 0.1 mbar. At top temperature 280°C, 22.9 g of colorless, syrupy 2,4,6-tripropyl-[1,3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide are obtained (yield 80%).
The thus obtained CPA is dissolved in 22.9 g of dichloromethane and can be used for further synthesis in this form.
Example 2: synthesis of 2,4,6-tripropyl-[1,3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide In a glass flask with stirrer, stopper, internal thermometer and distillation column, 33.0 g of propanephosphonic acid (0.27 mol) are dissolved under argon in 189.3 g of acetic anhydride (1.85 mol) and heated to reflux for 2 h.
Subsequently, the mixture of acetic acid and acetic anhydride is distilled off at 100 mbar. The external temperature is increased to 350°C and the vacuum to 0.1 mbar. At top temperature 280°C, 22.9 g of colorless, syrupy 2,4,6-tripropyl-[1,3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide are obtained (yield 80%).
The thus obtained CPA is dissolved in 22.9 g of dimethylformamide and can be used for further synthesis in this form.
Example 3: synthesis of 2,4,6-methyl-[1,3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide In a glass flask with stirrer, stopper, internal thermometer and distillation column, 40.2 g of ethanephosphonic acid (0.37 mol) are dissolved under argon in 204.9 g of acetic anhydride (2.01 mol) and heated to reflux for 2 h.
Subsequently, the mixture of acetic acid and acetic anhydride is distilled off at 100 mbar. The external temperature is increased to 350°C and the vacuum to 0.1 mbar. At top temperature 295°C, 20.2 g of colorless, syrupy 2,4,6-triethyl-[1,3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide are obtained (yield 66%).
Example 1: synthesis of 2,4,6-tripropyl-[1,3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide In a glass flask with stirrer, stopper, internal thermometer and distillation column, 33.0 g of propanephosphonic acid (0.27 mol) are dissolved under argon in 189.3 g of acetic anhydride (1.85 mol) and heated to reflux for 2 h.
Subsequently, the mixture of acetic acid and acetic anhydride is distilled off at 100 mbar. The external temperature is increased to 350°C and the vacuum to 0.1 mbar. At top temperature 280°C, 22.9 g of colorless, syrupy 2,4,6-tripropyl-[1,3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide are obtained (yield 80%).
The thus obtained CPA is dissolved in 22.9 g of dichloromethane and can be used for further synthesis in this form.
Example 2: synthesis of 2,4,6-tripropyl-[1,3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide In a glass flask with stirrer, stopper, internal thermometer and distillation column, 33.0 g of propanephosphonic acid (0.27 mol) are dissolved under argon in 189.3 g of acetic anhydride (1.85 mol) and heated to reflux for 2 h.
Subsequently, the mixture of acetic acid and acetic anhydride is distilled off at 100 mbar. The external temperature is increased to 350°C and the vacuum to 0.1 mbar. At top temperature 280°C, 22.9 g of colorless, syrupy 2,4,6-tripropyl-[1,3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide are obtained (yield 80%).
The thus obtained CPA is dissolved in 22.9 g of dimethylformamide and can be used for further synthesis in this form.
Example 3: synthesis of 2,4,6-methyl-[1,3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide In a glass flask with stirrer, stopper, internal thermometer and distillation column, 40.2 g of ethanephosphonic acid (0.37 mol) are dissolved under argon in 204.9 g of acetic anhydride (2.01 mol) and heated to reflux for 2 h.
Subsequently, the mixture of acetic acid and acetic anhydride is distilled off at 100 mbar. The external temperature is increased to 350°C and the vacuum to 0.1 mbar. At top temperature 295°C, 20.2 g of colorless, syrupy 2,4,6-triethyl-[1,3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide are obtained (yield 66%).
Example 4: synthesis of 2,4,6-trihexyl-[1;3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide In a glass flask with stirrer, stopper, internal thermometer and distillation . column, 44.8 g of hexanephosphonic acid (0.27 mol) are dissolved under argon in 189.3 g of acetic anhydride (1.85 mol) and heated to reflux for 2 h.
Subsequently, the mixture of acetic acid and acetic anhydride is distilled off at 100 mbar. The external temperature is increased to 350°C and the vacuum to 0.1 mbar. At top temperature 240°C, 30.0 g of colorless, syrupy 2,4,6-trihexyl-[1,3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide are obtained (yield 75%).
The thus obtained CPA is dissolved in 30 g of dichloromethane and can be used for further synthesis in this form.
Example 5: synthesis of 2,4,6-tricyclohexyl-[1,3,5,2,4,6]-trioxatriphos-phinane 2,4,6-trioxide In a glass flask with stirrer, stopper, internal thermometer and distillation column, 44.3 g of cyclohexylphosphonic acid (0.27 mol) are dissolved under argon in 189.3 g of acetic anhydride (1.85 mol) and heated to reflux for 2 h. Subsequently, the mixture of acetic acid and acetic anhydride is distilled off at 100 mbar. The external temperature is increased to 350°C
and the vacuum to 0.1 mbar. At top temperature 260°C, 27.6 g of colorless, syrupy 2,4,6-tricyclohexyl-[1,3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide are obtained (yield 70%).
The thus obtained CPA is dissolved in 27.6 g of dichloromethane and can be used for further synthesis in this form.
Example 6: Synthesis of N-acetyl-L-phenylalaninyl-L-alanine methyl ester 0.1 g of L-alanine methyl ester hydrochloride (0.7 mmol), 0.2 g of N-acetyl-L-phenylalanine (1 mmol) and 0.55 ml of N-methylmorpholine (5 mmol) are dissolved in 50 ml of dichloromethane and cooled to -10°C. 0.5 g of CPA
from example 1 (50% in CHzCIz; 0.8 mmol) is added slowly, and the mixture is stirred under cold conditions for 3 h and at room temperature for 72 h.
The solution is concentrated by evaporation and extracted with ethyl acetate and 1 N HCI solution, sat. NaHC03, sat. NaCI and dist. water. The organic phase is dried over magnesium sulfate, filtered off and concentrated by evaporation. 0.18 g of the white N-acetyl-L-phenylalaninyl-L-alanine methyl ester is obtained (88%).
Subsequently, the mixture of acetic acid and acetic anhydride is distilled off at 100 mbar. The external temperature is increased to 350°C and the vacuum to 0.1 mbar. At top temperature 240°C, 30.0 g of colorless, syrupy 2,4,6-trihexyl-[1,3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide are obtained (yield 75%).
The thus obtained CPA is dissolved in 30 g of dichloromethane and can be used for further synthesis in this form.
Example 5: synthesis of 2,4,6-tricyclohexyl-[1,3,5,2,4,6]-trioxatriphos-phinane 2,4,6-trioxide In a glass flask with stirrer, stopper, internal thermometer and distillation column, 44.3 g of cyclohexylphosphonic acid (0.27 mol) are dissolved under argon in 189.3 g of acetic anhydride (1.85 mol) and heated to reflux for 2 h. Subsequently, the mixture of acetic acid and acetic anhydride is distilled off at 100 mbar. The external temperature is increased to 350°C
and the vacuum to 0.1 mbar. At top temperature 260°C, 27.6 g of colorless, syrupy 2,4,6-tricyclohexyl-[1,3,5,2,4,6]-trioxatriphosphinane 2,4,6-trioxide are obtained (yield 70%).
The thus obtained CPA is dissolved in 27.6 g of dichloromethane and can be used for further synthesis in this form.
Example 6: Synthesis of N-acetyl-L-phenylalaninyl-L-alanine methyl ester 0.1 g of L-alanine methyl ester hydrochloride (0.7 mmol), 0.2 g of N-acetyl-L-phenylalanine (1 mmol) and 0.55 ml of N-methylmorpholine (5 mmol) are dissolved in 50 ml of dichloromethane and cooled to -10°C. 0.5 g of CPA
from example 1 (50% in CHzCIz; 0.8 mmol) is added slowly, and the mixture is stirred under cold conditions for 3 h and at room temperature for 72 h.
The solution is concentrated by evaporation and extracted with ethyl acetate and 1 N HCI solution, sat. NaHC03, sat. NaCI and dist. water. The organic phase is dried over magnesium sulfate, filtered off and concentrated by evaporation. 0.18 g of the white N-acetyl-L-phenylalaninyl-L-alanine methyl ester is obtained (88%).
Example 7: Synthesis of N-acetyl-L-phenylalaninyl-L-phenylalanine methyl ester 0.38 g of L-phenylalanine methyl ester hydrochloride (1.8 mmol), 0.37 g of N-acetyl-L-phenylalanine (1.7 mmol) and 1.6 ml of N-methylmorpholine (14.6 mmol) are dissolved in 30 ml of dimethylacetamide and cooled to 0°C. 1.2 ml of CPA from example 2 (50% in dimethylformamide, 1.9 mmol) are then added. The mixture is stirred at 0° for another 1 h and at room temperature for 12 h. The solution is concentrated by evaporation and extracted with ethyl acetate and 1 N HCI solution, sat. NaHC03, sat. NaCI
and dist. water. The organic phase is dried over magnesium sulfate, filtered off and concentrated by evaporation. 0.53 g of the white N-acetyl-L-phenylalaninyl-L-phenylalanine methyl ester is obtained (84%).
Comparative example 8: synthesis of N-acetyl-L-phenylalaninyl-L-phenylalanine methyl ester with the same amount of OPA as in example 5 0.38 g of L-phenylalanine methyl ester hydrochloride (1.8 mmol), 0.37 g of N-acetyl-L-phenylalanine (1.7 mmol) and 1.6 ml of N-methylmorpholine (14.6 mmol) are dissolved in 30 ml of dimethylacetamide and cooled to 0°C. 1.2 ml of OPA, prepared as described in EP 0 527 442, example 1 (50% in dimethylformamide, molar amount not possible because the composition is not known) are then added. The mixture is stirred at 0°C
for another 1 h and at room temperature for 12 h. The solution is concentrated by evaporation and extracted with ethyl acetate and 1 N HCI solution, sat.
NaHC03, sat. NaCI and dist. water. The organic phase is dried over magnesium sulfate, filtered off and concentrated by evaporation. 0.14 g of the white N-acetyl-L-phenylalaninyl-L-phenylalanine methyl ester is obtained (22%).
Comparative example 9: synthesis of N-acetyl-L-phenylalaninyl-L-phenylalanine methyl ester with an increased amount of OPA in comparison to example 5 0.38 g of L-phenylalanine methyl ester hydrochloride (1.8 mmol), 0.37 g of N-acetyl-L-phenylalanine (1.7 mmol) and 5.0 ml of N-methylmorpholine (45.5 mmol) are dissolved in 30 ml of dimethylacetamide and cooled to 0°C. 5 ml of OPA, prepared as described in EP 0 527 442, example 1 (50%
in dimethylformamide, molar amount not possible because the composition is not known) are then added. The mixture is stirred at 0°C for another 1 h ~
and at room temperature for 12 h. The solution is concentrated by evaporation and extracted with ethyl acetate and 1 N HCI solution, sat.
NaHC03, sat. NaCI and dist. water. The organic phase is dried over magnesium sulfate, filtered off and concentrated by evaporation. 0.55 g of 5. the white N-acetyl-L-phenylalaninyl-L-phenylalanine methyl ester is obtained (87%).
and dist. water. The organic phase is dried over magnesium sulfate, filtered off and concentrated by evaporation. 0.53 g of the white N-acetyl-L-phenylalaninyl-L-phenylalanine methyl ester is obtained (84%).
Comparative example 8: synthesis of N-acetyl-L-phenylalaninyl-L-phenylalanine methyl ester with the same amount of OPA as in example 5 0.38 g of L-phenylalanine methyl ester hydrochloride (1.8 mmol), 0.37 g of N-acetyl-L-phenylalanine (1.7 mmol) and 1.6 ml of N-methylmorpholine (14.6 mmol) are dissolved in 30 ml of dimethylacetamide and cooled to 0°C. 1.2 ml of OPA, prepared as described in EP 0 527 442, example 1 (50% in dimethylformamide, molar amount not possible because the composition is not known) are then added. The mixture is stirred at 0°C
for another 1 h and at room temperature for 12 h. The solution is concentrated by evaporation and extracted with ethyl acetate and 1 N HCI solution, sat.
NaHC03, sat. NaCI and dist. water. The organic phase is dried over magnesium sulfate, filtered off and concentrated by evaporation. 0.14 g of the white N-acetyl-L-phenylalaninyl-L-phenylalanine methyl ester is obtained (22%).
Comparative example 9: synthesis of N-acetyl-L-phenylalaninyl-L-phenylalanine methyl ester with an increased amount of OPA in comparison to example 5 0.38 g of L-phenylalanine methyl ester hydrochloride (1.8 mmol), 0.37 g of N-acetyl-L-phenylalanine (1.7 mmol) and 5.0 ml of N-methylmorpholine (45.5 mmol) are dissolved in 30 ml of dimethylacetamide and cooled to 0°C. 5 ml of OPA, prepared as described in EP 0 527 442, example 1 (50%
in dimethylformamide, molar amount not possible because the composition is not known) are then added. The mixture is stirred at 0°C for another 1 h ~
and at room temperature for 12 h. The solution is concentrated by evaporation and extracted with ethyl acetate and 1 N HCI solution, sat.
NaHC03, sat. NaCI and dist. water. The organic phase is dried over magnesium sulfate, filtered off and concentrated by evaporation. 0.55 g of 5. the white N-acetyl-L-phenylalaninyl-L-phenylalanine methyl ester is obtained (87%).
Claims (9)
1. A process for preparing cyclic phosphoric anhydrides of the formula (III) by a) reaction of phosphoric acid derivatives of the formula (I) with acetic anhydride at a temperature in the range from 30 to 150°C and simultaneous distillative removal of a mixture of acetic acid and acetic anhydride, b) subsequent reactive distillation of the oligomeric phosphoric anhydrides of the formula (II) obtained in step a) and conversion to the corresponding cyclic trimeric phosphoric anhydrides of the formula (III) where n is an integer from 0 to 300 and R are allyl, aryl or open-chain cyclic or branched C1 to C8-alkyl radicals, aryloxy, allyloxy or alkoxy having open-chain cyclic or branched C1 to C8-alkyl radicals.
2. The process as claimed in claim 1, wherein the cyclic trimeric phosphoric anhydrides formed in step b) are immediately dissolved in an organic solvent which is inert toward them.
3. The process as claimed in claim 1 and/or 2, wherein the ratio of acetic anhydride to phosphoric acid of the formula (I) is in the range of 20:1 and 1:1.
4. The process as claimed in at least one of claims 1 to 3 the reactive distillation in step b) is effected at a temperature in the range from 100 to 450°C (the internal reactor temperature) and a top temperature of from to 380°C.
5. The process as claimed in at least one of claims 1 to 4, wherein the pressure in a) the distillation of acetic acid and unconverted acetic anhydride is between 1 mbar and 1000 mbar, and b) in the reactive distillation of the oligomeric phosphonic anhydrides of the formula (II) to give the cyclic phosphonic anhydrides of the formula (III) is within a pressure range between 0.001 mbar and 500 mbar.
6. The process as claimed in at feast one of claims 1 to 5, which is carried out continuously.
7. The process as claimed in at least one of claims 1 to 6, wherein the resulting cyclic trimeric phosphonic anhydrides of the formula (III), after the reactive distillation, are dissolved in an organic solvent in a mixing ratio of solvent to phosphonic anhydride in the range of 10:1 and 1:10.
8. The process as claimed in at least one of claims 1 to 7, wherein the organic solvent is ligroin, sulfolane, DMSO, HMPT, NMP, pentane, hexane, heptane, octane, cyclopentane, cyclohexane, cycloheptane, cyclooctane, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, 1,1,2,2-tetrachloroethane, methyl acetate, ethyl acetate, propyl acetate, butyl acetate, dimethylformamide, diethylformamide; dimethylacetamide, diethylacetamide, diethyl ether, diisopropyl ether, tert-butyl methyl ether, THF, dioxane, acetonitrile, sulfolane, DMSO, HMPT, NMP or a mixture thereof.
9. The use of cyclic phosphonic anhydrides of the formula (III) obtainable by a process as claimed in at least one of claims 1 to 7 for condensation reactions, acylations and the preparation of heterocycles.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10333042A DE10333042B4 (en) | 2003-07-21 | 2003-07-21 | Process for the preparation of cyclic phosphonic anhydrides and their use |
DE10333042.9 | 2003-07-21 | ||
PCT/EP2004/007468 WO2005014604A2 (en) | 2003-07-21 | 2004-07-08 | Method for the production of cyclic phosphonic acid anhydrides |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2533173A1 true CA2533173A1 (en) | 2005-02-17 |
Family
ID=34111622
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002533173A Abandoned CA2533173A1 (en) | 2003-07-21 | 2004-07-08 | Method for the production of cyclic phosphonic acid anhydrides |
Country Status (14)
Country | Link |
---|---|
US (2) | US7473794B2 (en) |
EP (1) | EP1658299B1 (en) |
JP (1) | JP4757797B2 (en) |
KR (1) | KR20060063906A (en) |
CN (1) | CN100387606C (en) |
AT (1) | ATE443710T1 (en) |
AU (1) | AU2004263226A1 (en) |
BR (1) | BRPI0412747A (en) |
CA (1) | CA2533173A1 (en) |
DE (2) | DE10333042B4 (en) |
ES (1) | ES2331074T3 (en) |
HK (1) | HK1093989A1 (en) |
MX (1) | MXPA06000788A (en) |
WO (1) | WO2005014604A2 (en) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10333042B4 (en) * | 2003-07-21 | 2005-09-29 | Clariant Gmbh | Process for the preparation of cyclic phosphonic anhydrides and their use |
DE102008003677A1 (en) * | 2008-01-09 | 2009-07-16 | Archimica Gmbh | Process for the preparation of phosphonic anhydrides |
FR2928148B1 (en) * | 2008-02-28 | 2013-01-18 | Sanofi Aventis | PROCESS FOR PREPARING COMBRETASTATIN |
US20110166382A1 (en) * | 2008-06-09 | 2011-07-07 | Celtic Catalysts Limited | Processes for obtaining a phosphonic acid from a phosphonic acid anhydride |
DE102008055916A1 (en) * | 2008-11-05 | 2010-05-06 | Clariant International Limited | Process for the preparation of mono-hydroxy-functionalized dialkylphosphinic acids, esters and salts by means of allyl alcohols and their use |
JP5619756B2 (en) * | 2008-11-05 | 2014-11-05 | クラリアント・ファイナンス・(ビーブイアイ)・リミテッド | Process for the production of dialkylphosphinic acids, -esters and -salts using alkyl alcohol / acrolein and their use |
DE102008055914A1 (en) * | 2008-11-05 | 2010-05-06 | Clariant International Limited | A process for the preparation of mono-hydroxy-functionalized dialkylphosphinic acids, esters and salts by means of acroleins and their use |
EP2352740B1 (en) * | 2008-11-07 | 2014-09-24 | Clariant Finance (BVI) Limited | Method for producing dialkylphosphinic acids and esters and salts thereof by means of acrylic acid derivatives and use thereof |
DE102008056341A1 (en) | 2008-11-07 | 2010-05-12 | Clariant International Limited | Process for the preparation of mono-amino-functionalized dialkylphosphinic acids, esters and salts by means of acrylonitriles and their use |
DE102008056339A1 (en) * | 2008-11-07 | 2010-05-12 | Clariant International Limited | Process for the preparation of mono-amino-functionalized dialkylphosphinic acids, esters and salts and their use |
DE102008056342A1 (en) * | 2008-11-07 | 2010-05-12 | Clariant International Limited | Process for the preparation of dialkylphosphinic acids, esters and salts by means of acrylonitriles and their use |
US8772519B2 (en) | 2008-11-11 | 2014-07-08 | Clariant Finance (Bvi) Limited | Process for preparing mono-allyl-functionalized dialkylphosphinic acids, salts and esters thereof with allylic compounds, and the use thereof |
DE102008060035A1 (en) * | 2008-12-02 | 2010-06-10 | Clariant International Limited | Process for the preparation of monohydroxy-functionalized dialkylphosphinic acids, esters and salts by means of vinyl esters of a carboxylic acid and their use |
DE102008060036A1 (en) * | 2008-12-02 | 2010-06-10 | Clariant International Limited | Process for the preparation of mono-carboxy-functionalized dialkylphosphinic acids, esters and salts by means of vinyl esters of a carboxylic acid and their use |
DE102008060535A1 (en) | 2008-12-04 | 2010-06-10 | Clariant International Limited | Process for the preparation of mono-carboxy-functionalized dialkylphosphinic acids, esters and salts by means of vinyl ethers and their use |
DE102008063642A1 (en) | 2008-12-18 | 2010-06-24 | Clariant International Limited | Process for the preparation of monocarboxy-functionalized dialkylphosphinic acids, esters and salts by means of alkylene oxides and their use |
DE102008063668A1 (en) * | 2008-12-18 | 2010-07-01 | Clariant International Limited | Process for the preparation of alkylphosphonic acids, esters and salts by oxidation of alkylphosphonous acids and their use |
DE102008063627A1 (en) | 2008-12-18 | 2010-06-24 | Clariant International Limited | Process for the preparation of monohydroxy-functionalized dialkylphosphinic acids, esters and salts by means of ethylene oxide and their use |
KR101697948B1 (en) | 2008-12-18 | 2017-01-19 | 클라리언트 파이넌스 (비브이아이)리미티드 | Process for preparing ethylenedialkylphosphinic acids, esters and salts by means of acetylene and use thereof |
DE102008064012A1 (en) | 2008-12-19 | 2010-06-24 | Clariant International Limited | Halogen-free adducts of alkylphosphonous acid derivatives and diester-forming olefins, halogen-free processes for their preparation and their use |
DE102008064003A1 (en) | 2008-12-19 | 2010-06-24 | Clariant International Limited | Process for the preparation of monofunctionalized dialkylphosphinic acids, esters and salts and their use |
CN102858739A (en) * | 2010-03-10 | 2013-01-02 | 斯索恩有限公司 | A process for amidation of pyrrole carboxylate compounds |
EP2627636B1 (en) | 2010-10-14 | 2015-09-02 | Synthon BV | Process for making bortezomib and the intermediates for the process |
DE102011108324A1 (en) * | 2011-07-25 | 2013-01-31 | Merck Patent Gmbh | Process for the preparation of bis (perfluoroalkyl) phosphinic anhydrides |
CN103483386B (en) * | 2013-08-30 | 2016-03-02 | 山东汇海医药化工有限公司 | A kind of preparation method of 1-propyl phosphonous acid cyclic anhydride of improvement |
CN107331893B (en) * | 2016-04-29 | 2020-03-10 | 华为技术有限公司 | High-temperature lithium ion battery electrolyte, preparation method thereof and high-temperature lithium ion battery |
CN107011384B (en) * | 2017-04-24 | 2019-02-15 | 中节能万润股份有限公司 | A kind of preparation method of ring-type propyl phosphonous acid acid anhydride |
US20200199159A1 (en) * | 2017-08-25 | 2020-06-25 | Synthon B.V. | Process for making ixazomib or intermediates therefor |
CN108314693B (en) * | 2018-01-09 | 2020-06-09 | 苏州亚科科技股份有限公司 | Method for improving stability of alkyl phosphonic acid anhydride derivative |
CN115551800A (en) | 2020-05-08 | 2022-12-30 | 纮康公司 | Process for producing acid anhydride |
CN111635434B (en) * | 2020-07-20 | 2023-04-07 | 苏州昊帆生物股份有限公司 | Synthesis method of 1-propylphosphoric cyclic anhydride |
CN113185622B (en) * | 2021-04-29 | 2022-05-24 | 华南理工大学 | High-phosphorus-content chitosan derivative, preparation method thereof and application thereof in loading of nano zero-valent iron |
KR102464766B1 (en) * | 2021-07-09 | 2022-11-07 | 동우 화인켐 주식회사 | Electrolyte composition and secondary battery comprising the same |
CN114195826B (en) * | 2021-09-13 | 2023-06-23 | 洪湖市一泰科技有限公司 | Treatment method and treatment device for distillation still residues in cyclic phosphonic acid anhydride production |
CN114763364A (en) * | 2021-11-18 | 2022-07-19 | 黑龙江豪运药业有限公司 | Synthesis method of 1-propyl phosphoric anhydride |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2758580A1 (en) | 1977-12-29 | 1979-07-05 | Hoechst Ag | PROCESS FOR PRODUCTION OF PHOSPHINE AND PHOSPHONIC ACID ANHYDRIDES |
DE2811628A1 (en) * | 1978-03-17 | 1979-09-27 | Hoechst Ag | ALKANE-BIS-ALKYL-PHOSPHIC ACID ANHYDRIDES AND PROCESS FOR THE PREPARATION OF ALKANE PHOSPHONE AND ALKANE-BIS-ALKYLPHOSPHINIC ANHYDRIDES |
DE3411224A1 (en) * | 1984-03-27 | 1985-10-10 | Hoechst Ag, 6230 Frankfurt | METHOD FOR THE RACEMATAR PRODUCTION OF INTERMEDIATE PEPTIDE PRODUCTS OF THE GONADORELIN AND GONADORELINANALOGA SYNTHESIS AND NEW INTERMEDIATE PRODUCTS IN THIS METHOD |
JPH01279921A (en) * | 1988-05-06 | 1989-11-10 | Idemitsu Kosan Co Ltd | Preparation of polyamide |
US5191065A (en) * | 1988-11-22 | 1993-03-02 | Hoechst Aktiengesellschaft | Process for the preparation of tripeptides |
US5319138A (en) * | 1991-08-08 | 1994-06-07 | Hoechst Aktiengesellschaft | Process for the preparation of pure propanephosphonic anhydride |
JPH0686478A (en) | 1991-08-29 | 1994-03-25 | Nec Home Electron Ltd | Electronic apparatus |
JPH09157284A (en) * | 1995-12-11 | 1997-06-17 | Ono Pharmaceut Co Ltd | Production of glucopyranose derivative |
DE19802969A1 (en) | 1998-01-27 | 1999-07-29 | Hoechst Marion Roussel De Gmbh | Preparation of imidazole derivatives, useful as intermediates for angiotensin II receptor antagonists, by cyclization of aminoacrylate esters |
DE10063493A1 (en) | 2000-12-20 | 2002-06-27 | Bayer Ag | Production of substituted aryl ketone compounds for use as agrochemicals, e.g. herbicides, involves reacting C-H acid compounds with substituted benzoic acids in presence of cyclic phosphonic acid anhydride |
DE10333042B4 (en) * | 2003-07-21 | 2005-09-29 | Clariant Gmbh | Process for the preparation of cyclic phosphonic anhydrides and their use |
-
2003
- 2003-07-21 DE DE10333042A patent/DE10333042B4/en not_active Expired - Fee Related
-
2004
- 2004-07-08 WO PCT/EP2004/007468 patent/WO2005014604A2/en active Application Filing
- 2004-07-08 CA CA002533173A patent/CA2533173A1/en not_active Abandoned
- 2004-07-08 JP JP2006520716A patent/JP4757797B2/en active Active
- 2004-07-08 BR BRPI0412747-1A patent/BRPI0412747A/en not_active IP Right Cessation
- 2004-07-08 MX MXPA06000788A patent/MXPA06000788A/en active IP Right Grant
- 2004-07-08 AT AT04740776T patent/ATE443710T1/en not_active IP Right Cessation
- 2004-07-08 AU AU2004263226A patent/AU2004263226A1/en not_active Abandoned
- 2004-07-08 KR KR1020067001379A patent/KR20060063906A/en not_active Application Discontinuation
- 2004-07-08 CN CNB2004800199255A patent/CN100387606C/en not_active Expired - Fee Related
- 2004-07-08 US US10/565,470 patent/US7473794B2/en active Active
- 2004-07-08 EP EP04740776A patent/EP1658299B1/en active Active
- 2004-07-08 ES ES04740776T patent/ES2331074T3/en active Active
- 2004-07-08 DE DE502004010124T patent/DE502004010124D1/en active Active
-
2007
- 2007-01-10 HK HK07100313.3A patent/HK1093989A1/en unknown
-
2008
- 2008-04-02 US US12/061,124 patent/US7829736B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN100387606C (en) | 2008-05-14 |
ES2331074T3 (en) | 2009-12-21 |
JP4757797B2 (en) | 2011-08-24 |
CN1823079A (en) | 2006-08-23 |
US7829736B2 (en) | 2010-11-09 |
AU2004263226A1 (en) | 2005-02-17 |
MXPA06000788A (en) | 2006-04-18 |
DE10333042B4 (en) | 2005-09-29 |
DE502004010124D1 (en) | 2009-11-05 |
BRPI0412747A (en) | 2006-09-26 |
WO2005014604A2 (en) | 2005-02-17 |
US20080183009A1 (en) | 2008-07-31 |
HK1093989A1 (en) | 2007-03-16 |
EP1658299B1 (en) | 2009-09-23 |
US7473794B2 (en) | 2009-01-06 |
US20060264654A1 (en) | 2006-11-23 |
KR20060063906A (en) | 2006-06-12 |
WO2005014604A3 (en) | 2005-05-06 |
EP1658299A2 (en) | 2006-05-24 |
DE10333042A1 (en) | 2005-03-03 |
ATE443710T1 (en) | 2009-10-15 |
JP2006528140A (en) | 2006-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7829736B2 (en) | Method for the production of cyclic phosphonic acid anhydrides | |
US8450488B2 (en) | Process for the preparation of [1-hydroxy-2-(3-pyridinyl)ethylidene] bisphosphonic acid and hemipentahydrate monosodium salt thereof | |
JP2706061B2 (en) | Method for producing phosphorus-containing dicarboxylic acid | |
CN104812765A (en) | Method for the synthesis of alpha-aminoalkylenephosphonic acid | |
US6388125B1 (en) | Process for preparing phosphinic acids | |
US7741518B2 (en) | Method for producing trifluoromethanesulfonic anhydride | |
CN102448974A (en) | Method for the manufacture of phosphonoalkyl iminodiacetic acids | |
JP4860080B2 (en) | Method for producing N-phosphonomethylglycine | |
JPS603317B2 (en) | Method for producing chlorinated phosphite | |
CN101054391A (en) | Chiral (1-phenylethylamino)methyl phosphonic acid and preparation method thereof | |
CN109627262A (en) | Tolysulfonyl oxygen methylmethylene ethyl diphosphonic acid and preparation method thereof, impurity of tenofovir and preparation method thereof | |
EP1810975B1 (en) | Method for producing phosphonates having an alcoholic hydroxy group | |
JP3896113B2 (en) | Method for producing N-phosphonomethylglycine | |
JP2012528128A (en) | Process for the production of dialkyl phosphites | |
JP2012528122A (en) | Process for the production of dialkyl phosphites | |
CN102448971A (en) | Method for the manufacture of dialkylphosphites | |
WO2008157050A1 (en) | Processes for manufacturing bisphosphonic acids | |
US20040236144A1 (en) | Method for producing $g(a)-aminophosphonic acids | |
JP2000191634A (en) | Production of trifluoromethane sulfonyl chloride | |
JP3456633B2 (en) | Purification method of trifluoromethanesulfonic anhydride | |
JPH0415794B2 (en) | ||
RU2070886C1 (en) | Method of acid phosphite or phosphonite producing | |
JPH08198886A (en) | Production of bis(2-carboxyethyl)alkylphosphine oxide and its derivative | |
CN1056498A (en) | Phosphonylation processes | |
JPH093083A (en) | Novel oxaphospholine and its production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |